Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity

Journal of Infectious Diseases

Volumn 194, Issue 2, 2006, Pages 216-221

  Lipner, Ettie M ^a   Dembele, Noumouza ^c   Souleymane, Sanou ^d   Alley, William Soumbey ^c   Prevots, D Rebecca ^a   Toe, Laurent ^c   Boatin, Boayke ^c   Weil, Gary J ^b   Nutman, Thomas B ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; PARASITE ANTIGEN OV 16; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROL SYSTEM; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; ONCHOCERCIASIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGING; ANTIBODIES, HELMINTH; BURKINA FASO; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; ONCHOCERCIASIS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 33746115659     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505081     Document Type: Article

References (22)

1. World Health Organization. Strategic Direction for Onchocerciasis Research. Geneva: World Health Organization, 2002. Available at: http://www.who.int/tdr/diseases/oncho/diseaseinfo.htm. Accessed 12 June 2006.
2. Burnham G. Onchocerciasis. Lancet 1998; 351:1341-5.
3. World Health Organization statistics. Geneva: World Health Organization, 2005. Available at: http://www.who.int/blindness/partnerships/ onchocerciasis_treatment/en/index.html. Accessed 12 June 2006.
4. Richards FO Jr, Boatin B, Sauerbrey M, Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol 2001; 17:558-63.
5. Yameogo L, Toe L, Hougard JM, Boatin BA, Unnasch TR. Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnosum sensu lato: results of a field trial in an area subject to successful vector control. Am J Trop Med Hyg 1999; 60:124-8.
6. Taylor HR, Munoz B, Keyvan-Larijani E, Greene BM. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med Hyg 1989; 41:467-71.
7. Remme J, Ba O, Dadzie KY, Karam M. A force-of-infection model for Onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 1986; 64:667-81.
8. Boatin BA, Toe L, Alley ES, Dembele N, Weiss N, Dadzie KY. Diagnostics in Onchocerciasis: future challenges. Ann Trop Med Parasitol 1998;92(Suppl 1):S41-5.
9. Weil GJ, Steel C, Liftis F, et al. A rapid-format antibody test for diagnosis of Onchocerciasis. J Infect Dis 2000; 182:1796-9.
10. Vincent JA, Lustigman S, Zhang S, Weil GJ. A comparison of newer tests for the diagnosis of onchocerciasis. Ann Trop Med Parasitol 2000; 94:253-8.
11. Ramachandran CP. Improved immunodiagnostic tests to monitor onchocerciasis control programmes - a multicenter effort. Parasitol Today 1993; 9:77-9.
12. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science 1991;251:1603-5.
13. Remme JHF. Research for control: the onchocerciasis experience. Trop Med Int Health 2004; 9:243-54.
14. Satoguina J, Mempel M, Larbi J, et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 2002;4:1291-300.
15. Newland HS, Kaiser A, Taylor HR. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. Trop Med Parasitol 1987; 38:143-1.
16. Toe L, Adjami AG, Boatin BA, et al. Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in west Africa. Trans R Soc Trop Med Hyg 2000; 94:519-25.
17. Remme J, Baker RH, De Sole G, et al. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Trop Med Parasitol 1989; 40:367-74.
18. Guillet P, Seketeli A, Alley ES, et al. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Bull World Health Organ 1995; 73:199-205.
19. Taylor HR, Pacque M, Munoz B, Greene BM. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 1990;250:116-8.
20. Boussinesq M, Chippaux JP, Ernould JC, Quillevere D, Prod'hon J. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon. Am J Trop Med Hyg 1995; 53:63-7.
21. Trpis M, Childs JE, Fryauff DJ, et al. Effect of mass treatment of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa. Am J Trop Med Hyg 1990; 42:148-56.
22. Boatin BA, Hougard JM, Alley ES, et al. The impact of mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol 1998; 92(Suppl 1):S46-60.